It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. Global Collaborators

About OtsukaGlobal Collaborators

Global collaborators with whom we have a business alliance.

Pharmaceutical products

Central Nervous System

UCB S.A.
UCB S.A. (Belgium), UCB Japan
  • Joint development and sales promotion of E Keppra in Japan
  • Development and sales of NEUPRO Patch in Japan
H. Lundbeck A/S
H. Lundbeck A/S (Denmark)
  • Joint development and sales promotion of ABILIFY Maintena (Europe, North America, Australia)
  • Joint development and sales promotion of REXULTI
  • Joint development and commercialization of NALMEFENE in Japan
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. (U.S.)
  • Collaboration on development and commercialization of first-ever digital medicine in the U.S.
IBM
IBM Japan
  • Development of digital health solutions business in Japan
Teva Pharmaceutical Industries, Ltd.
Teva Pharmaceutical Industries, Ltd. (Israel)
  • Joint development and sales of fremanezumab in Japan
TWO CELLS
TWO CELLS (Japan)
  • Research and development of treatments using cells derived from mesenchymal stem cells

Oncology

TAKARA BIO INC.
TAKARA BIO INC. (Japan)
  • Exclusive rights for developing and marketing HF10 in Japan
Pierre Fabre
Pierre Fabre (France)
  • Business related to Busulfex in European countries
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (U.S.)
  • Joint business related to SPRYCEL
X-Chem, Inc.
X-Chem, Inc. (U.S.)
  • Collaborative research to advance the discovery process for new Otsuka drug compounds

Cardiovascular and Renal

Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc.
  • Exclusive rights for developing and marketing vadadustat in U.S.
NEC Corporation
NEC Corporation
  • Joint business related to "Pletaal Assist System" in Japan

Ophthalmology

Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. (Japan)
  • Co-promotion of Mikeluna combination ophthalmic solution, Mikelan ophthalmic solution and Mikelan LA ophthalmic solution
    Co-marketing of OPEGUARD NEO KIT
Toyama Chemical Co., Ltd.
Toyama Chemical Co., Ltd. (Japan)
  • License for OZEX ophthalmic solution

Diagnostics

Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. (Japan)
  • Co-marketing of RAPIRUN and Uropaper
  • Co-research and co-development of diagnostics
Denka Seiken Co., Ltd.
Denka Seiken Co., Ltd. (Japan)
  • License for Quick Navi series